PARP1 and C syndrome: However, in our case, this effect was not seen, probably due to the decline of mitochondrial function that characterizes CS syndrome and is derived from the decreased activation of the NAD+/SIRT1/PGC1a axis triggered by the hyperactivation of PARP1 due to chronic oxidative DNA damage [57].